Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Cunningham

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Veterinary Immunology and Immunopathology|April 14, 2009
Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formationB Dunkel, K J Rickards, D Werling, et al.
British Journal of Pharmacology|March 1, 1981
Leukotriene B4: a mediator of vascular permeabilityM A Bray, F M Cunningham, A W Ford-Hutchinson, et al.
British Journal of Pharmacology|March 1, 1978
Effects of D-penicillamine and levamisole on delayed hypersensitivity reactions in the rat and mouse [proceedings]F M Cunningham, A W Ford-Hutchinson, M J Smith, et al.
Journal of Veterinary Pharmacology and Therapeutics|April 2, 2003
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine bloodK J Rickards, C P Page, P Lees, et al.
Equine Veterinary Journal|November 5, 1997
Influence of antigen challenge on platelet responsiveness in horses with chronic obstructive pulmonary diseaseJ M Ablett, S M Fairbairn, C P Page, et al.
Veterinary Immunology and Immunopathology|October 25, 2000
Cloning of equine chemokines eotaxin, monocyte chemoattractant protein (MCP)-1, MCP-2 and MCP-4, mRNA expression in tissues and induction by IL-4 in dermal fibroblastsC Benarafa, F M Cunningham, A S Hamblin, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 11, 2005
The role of protein kinase C in regulating equine eosinophil adherence and superoxide productionM F Sepulveda, E C Greenaway, M Avella, et al.
Journal of Veterinary Pharmacology and Therapeutics|June 1, 1996
A study of the effect of a platelet activating factor (PAF) receptor antagonist on antigen challenge of horses with chronic obstructive pulmonary diseaseK A Marr, S M Fairbairn, C P Page, et al.
Research in Veterinary Science|September 1, 1996
Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary diseaseS M Fairbairn, K A Marr, P Lees, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 19, 2010
Endotoxin-induced HIF-1alpha stabilisation in equine endothelial cells: synergistic action with hypoxiaA C Brooks, N Menzies-Gow, S R Bailey, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Veterinary Immunology and Immunopathology|April 14, 2009
Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formationB Dunkel, K J Rickards, D Werling, et al.
British Journal of Pharmacology|March 1, 1981
Leukotriene B4: a mediator of vascular permeabilityM A Bray, F M Cunningham, A W Ford-Hutchinson, et al.
British Journal of Pharmacology|March 1, 1978
Effects of D-penicillamine and levamisole on delayed hypersensitivity reactions in the rat and mouse [proceedings]F M Cunningham, A W Ford-Hutchinson, M J Smith, et al.
Journal of Veterinary Pharmacology and Therapeutics|April 2, 2003
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine bloodK J Rickards, C P Page, P Lees, et al.
Equine Veterinary Journal|November 5, 1997
Influence of antigen challenge on platelet responsiveness in horses with chronic obstructive pulmonary diseaseJ M Ablett, S M Fairbairn, C P Page, et al.
Veterinary Immunology and Immunopathology|October 25, 2000
Cloning of equine chemokines eotaxin, monocyte chemoattractant protein (MCP)-1, MCP-2 and MCP-4, mRNA expression in tissues and induction by IL-4 in dermal fibroblastsC Benarafa, F M Cunningham, A S Hamblin, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 11, 2005
The role of protein kinase C in regulating equine eosinophil adherence and superoxide productionM F Sepulveda, E C Greenaway, M Avella, et al.
Journal of Veterinary Pharmacology and Therapeutics|June 1, 1996
A study of the effect of a platelet activating factor (PAF) receptor antagonist on antigen challenge of horses with chronic obstructive pulmonary diseaseK A Marr, S M Fairbairn, C P Page, et al.
Research in Veterinary Science|September 1, 1996
Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary diseaseS M Fairbairn, K A Marr, P Lees, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 19, 2010
Endotoxin-induced HIF-1alpha stabilisation in equine endothelial cells: synergistic action with hypoxiaA C Brooks, N Menzies-Gow, S R Bailey, et al.
Pageof 9